Microscopic study of chronic charcot arthropathy foot bones contributes to understanding pathogenesis - A preliminary report.
Journal
Histology and histopathology
ISSN: 1699-5848
Titre abrégé: Histol Histopathol
Pays: Spain
ID NLM: 8609357
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
pubmed:
12
9
2019
medline:
27
3
2021
entrez:
12
9
2019
Statut:
ppublish
Résumé
Charcot arthropathy (CA) is non-infective, chronic destructive condition affecting the pes architecture of long standing diabetic patients with neuropathy. Even though several theories have emerged to disclose its pathogenesis, inflammatory cytokine induced osteoclastogenesis stands as the chief culprit. Studies on micro-architecture of foot bones of acute stage CA patients, describes mainly destructive phase of bone remodelling. Increased osteoclast cell activity is reported in all studies communicated. No study has to the best of our knowledge detailed the microscopic structure of chronic stage CA foot bones. To study the microscopic structure of foot bones in patients with chronic CA. Foot bones were collected from the feet of chronic CA patients (six in number) who underwent corrective foot surgery in the Department of Podiatric Surgery of a tertiary care hospital. Control samples were collected from the feet of age matched non-diabetic controls (2 in number). The samples were fixed in formalin, decalcified in 10% nitric acid, processed, sectioned and stained with haematoxylin and eosin. Histopathology and histomorphometry analysis were performed by two different pathologists. Trabeculae of chronic CA foot bones exhibited mainly a lamellar architecture, with reduced number of osteocytes and plenty of empty lacunae. Trabecular connectivity was lost and trabeculae showed considerable thinning. Trabecular osteoids lined by active osteoblast cells was a remarkable observation. Bone area was also considerably reduced in chronic CA foot bones. Chronic stage CA foot bones presented features of both healing and fragile bone. The compromised bone quality may be due to thin and fragmented trabecular structure and reduced cellularity.
Identifiants
pubmed: 31508805
pii: HH-18-162
doi: 10.14670/HH-18-162
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
443-448Subventions
Organisme : -
ID : -
Références
Baumhauer J.F., O'Keefe R.J., Schon L.C. and Pinzur M.S. (2006). Cytokine-induced osteoclastic bone resorption in Charcot arthropathy: an immunohistochemical study. Foot Ankle Int. 27, 797- 800.
pubmed: 17054880
Delaisse J.M. (2014). The reversal phase of the bone remodeling cycle: cellular prerequisites for coupling resorption and formation. Bonekey Rep. 3, 561.
pmcid: PMC4130129
pubmed: 25120911
Dodd A. and Daniels T.R. (2018). Charcot neuroarthropathy of the foot and ankle. J. Bone Joint Surg. Am. 100, 696-711.
pubmed: 29664858
Farber D.C., Juliano P.J., Cavanagh P.R., Ulbrecht J. and Caputo G. (2002). Single stage correction with external fixation of the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int. 23, 130-134.
pubmed: 11858333
Feng X. and McDonald J. (2011). Disorders of bone remodelling. Annu. Rev. Pathol. 6, 121-145.
pmcid: PMC3571087
pubmed: 20936937
Gouveri E. and Papanas N. (2011). Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice. World J. Diabetes 2, 59-65.
pmcid: PMC3116009
pubmed: 21691556
Graham J.M., Ayati B.P., Holstein S.A. and Martin J.A. (2013). The role of osteocytes in targeted bone remodeling: a mathematical model. PLoS One 8, e63884.
pmcid: PMC3661588
pubmed: 23717504
Guven M.F, Karabiber A., Kaynak G. and Ogut T. (2013). Conservative and surgical treatment of the chronic Charcot foot and ankle. Diabet. Foot Ankle 4, 21177.
pmcid: PMC3733018
pubmed: 23919114
Johnson-Lynn S.E., McCaskie A.W., Coll A.P. and Robinson A.H.N. (2018). Neuroarthropathy in diabetes: pathogenesis of Charcot arthropathy. Bone Joint Res. 7, 373-378.
pmcid: PMC5987696
pubmed: 29922458
Kayanak G., Birsel O., Guven M.F. and Ogut T. (2013). An overview of the Charcot foot pathophysiology. Diabet. Foot Ankle 4, 21117.
pmcid: PMC3733015
pubmed: 23919113
La Fontaine J., Shibuya N., Sampson H.W. and Valderramma P. (2011). Trabecular quality and cellular characteristics of normal, diabetic, and Charcot bone. J. Foot Ankle Surg. 50, 648-653.
pubmed: 21705241
Larson S.A. and Burns P.R. (2012). The pathogenesis of Charcot neuroarthropathy: current concepts. Diabet. Foot Ankle 3, 12236.
pmcid: PMC3284308
pubmed: 22396834
Mascarenhas J.V. and Edward B. (2014). The Charcot foot as a complication of diabetes. Curr. Diab. Rep. 14, 561.
pubmed: 25354828
Milovanovic P., Vom Scheidt A., Mletzko K., Sarau G., Püschel K., Djuric M., Amling M., Christiansen. S. and Busse B. (2018). Bone tissue ageing affects mineralization of cement lines. Bone 110, 187- 193.
pubmed: 29427789
Nakashima T. (2013). Regulation of bone homoeostasis by bone cells. Clin. Calcium 23, 218-228.
pubmed: 23354089
Papanas N. and Maltezos E. (2013). Etiology, pathophysiology and classifications of the diabetic Charcot foot. Diabet. Foot Ankle 4, 20872.
pmcid: PMC3661901
pubmed: 23705058
Petrova N.L., Dew T.K. and Musto R.L. (2015). Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy. Diabetic Med. 32, 267-273.
pubmed: 25251588
Rogers L.C., Frykberg R.G., Armstrong D.G., Boulton A.J., Edmonds M., Van G.H., Hartemann A., Game F., Jeffcoate W., Jirkovska A., Jude E., Morbach S., Morrison W.B., Pinzur M., Pitocco D., Sanders L., Wukich D.K. and Uccioli L. (2011). The Charcot foot in diabetes. Diabetes Care 34, 2123-2129.
pmcid: PMC3161273
pubmed: 21868781
Rosenbaum A.J. and DiPreta J.A. (2015). Classifications in brief: Eichenholtz classification of Charcot arthropathy. Clin. Orthop. Relat. Res. 473, 1168-1171.
pmcid: PMC4317422
pubmed: 25413713
Shetty S., Kapoor N., Bondu J.D., Thomas N. and Paul T.V. (2016). Bone turnover markers: Emerging tool in the management of osteoporosis. Indian J. Endocrinol. Metab. 20, 846-852.
pmcid: PMC5105571
pubmed: 27867890
Siddiqui J.A. and Partridge N.C. (2014). Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. Physiology 31, 233-245.
pmcid: PMC6734079
pubmed: 27053737
Sinha S., Munichoodappa C.S. and Kozak G.P. (1972). Neuroarthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases) Medicine (Baltimore) 51, 191-210.
pubmed: 5021769
Vidal B., Pinto A., Galvao M.J., Santos A.R., Rodrigues A., Cascao R., Abdulghani S., Caetano-Lopes J., Ferreira A., Fonseca J.E. and Canhao H. (2012). Bone histomorphometry revisited. Acta Reumatol. Port. 37, 294-300.
pubmed: 24126421